常熟市第一人民医院2014—2017年中成药使用情况分析

常熟市第一人民医院2014—2017年中成药使用情况分析

目的了解常熟市第一人民医院（以下简称“本院”）2014-2017年中成药应用情况，为临床合理用药提供参考。方法从本院信息系统调取2014-2017年中成药相关数据，按照世界卫生组织推荐的日均费用，对中成药的销售额、年增长率、用药频度、排序比和限定日费用等进行统计分析。结果2014-2017年，本院中成药的年销售额依次为4915.52、5135.27、4946.37、4565.04万元，2015、2016、2017年与上年相比分别增长4.47%、-3.68%、-7.71%，占医院药品销售总额比例为13.63%、13.36%、12.83%、12.44%。在各剂型中，销售额排序居前3位是胶囊剂（32.67%）、注射剂（25.21%）和片剂（14.71%）。在各类别中，销售额排序居前3位的是理血剂、清热剂和补益剂，DDDs排序居前3位的是理血剂、妇科类和补益剂。单品种销售额排序列首位的有注射用丹参多酚酸盐、蒲地蓝消炎口服液和注射用血栓通（冻干），单品种DDDs 排序列首位的有银杏酮酯分散片和蒲地蓝消炎口服液。结论本院中成药使用渐趋合理，在防治疾病中作用和优势不断显现，但仍存在一些不合理用药问题，有待进一步加强管理。

Abstract：Objective To understand the application situation of Chinese patent medicine during 2014-2017 in Changshu No.1 People’s Hospital （hereinafter referred to as “our hospital”）；To provide references for clinical rational medication. Metheds The data of Chinese patent medicine used in our hospital in 2014-2017 were retrieved from our hospital HIS. The consumption sum，annual growth rate，DDDs，sorting ratio and DDDc of Chinese patent medicine were analyzed statistically according to the defined daily dose recommended by WHO. Results During 2014-2017，the consumption sums of Chinese patent medicine were 49.155 2 million yuan，51.352 7 million yuan，49.463 7 million yuan and 45.650 4 million yuan，respectively. The consumption sums of Chinese patent medicine of 2015，2016 and 2017 increased by 4.47%，-3.68% and -7.71%，respectively. The proportions of consumption sum of Chinese patent medicine in all medicines were 13.63% in 2014，13.36% in 2015，12.83% in 2016 and 12.44% in 2017. Of all the dosage forms of Chinese patent medicine，capsule （32.67%），injection （25.21%）and tablet （14.71%）ranked the top 3 on the list of consumption sum. Of all the single kinds of Chinese patent medicine，blood rationing medicine，heat-clearing medicine and tonifying medicine ranked the top 3 on the list of consumption sum. The blood rationing medicine，gynecologic medicine and tonifying medicine ranked the top 3 on the list of DDDs. The first varieties of single item of consumption sum were salvianolate injection，Pudilan Xiaoyan Oral Liquid and Xueshuantong Injection （freeze-dried）. The first varieties of single items of DDDs were Yinxing Tongzhi Dispersible Tablet and Pudilan Xiaoyan Oral Liquid. Conclusion The use of Chinese patent medicine in our hospital is becoming more reasonable，and the role and advantages in the prevention and control of diseases are constantly emerging. However，there are still problems about irrational medication，which need to be further strengthened.Keywords：Chinese patent medicine；consumption sum；DDDs；DDDc；analysis；rational medication